Evidence map›Paper›PMID 30609290›Full record

Observational studyJournal of thrombosis and haemostasis : JTH2019

Towards patient-specific management of trauma hemorrhage: the effect of resuscitation therapy on parameters of thromboelastometry.

Nicole P Juffermans, Mathijs R Wirtz, Kirsten Balvers, Kjersti Baksaas-Aasen, Susan van Dieren, Christine Gaarder, Paul A Naess, Simon Stanworth, Pär I Johansson, Jakob Stensballe and 4 more

Open access · hybridAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Journal of thrombosis and haemostasis : JTH, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
4.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Visco-elastic testing in traumatic bleeding.Intensive care medicine · 2024
    Article
  5. Article
  6. Observational
  7. Variations and obstacles in the use of coagulation factor concentrates for major trauma bleeding across Europe: outcomes from a European expert meeting.European journal of trauma and emergency surgery : official publication of the European Trauma Society · 2022
    Review
  8. Article
  9. Article
  10. Fibrinogen Early In Severe Trauma studY (FEISTY): results from an Australian multicentre randomised controlled pilot trial.Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine · 2021
    Article
  11. Article
  12. "TEG talk": expanding clinical roles for thromboelastography and rotational thromboelastometry.Hematology. American Society of Hematology. Education Program · 2020
    Article
  13. Observational
  14. Article
  15. Observational
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 5 countries.

Nicole P JuffermansDepartment of Intensive Care Medicine, Amsterdam UMC, Academic Medical Center, Amsterdam, the Netherlands.
Mathijs R WirtzDepartment of Intensive Care Medicine, Amsterdam UMC, Academic Medical Center, Amsterdam, the Netherlands.
Kirsten BalversDepartment of Intensive Care Medicine, Amsterdam UMC, Academic Medical Center, Amsterdam, the Netherlands.
Kjersti Baksaas-AasenDepartment of Traumatology, Oslo University Hospital, Oslo, Norway.
Susan van DierenDepartment of Intensive Care Medicine, Amsterdam UMC, Academic Medical Center, Amsterdam, the Netherlands.
Christine GaarderDepartment of Traumatology, Oslo University Hospital, Oslo, Norway.
Paul A NaessDepartment of Traumatology, Oslo University Hospital, Oslo, Norway.
Simon StanworthNHS Blood and Transplant/Oxford University Hospitals NHS Trust, John Radcliffe Hospital, Oxford, UK.
Pär I JohanssonDepartment of Anesthesiology and Trauma Center, Center for Head and Orthopedics, and Section for Transfusion Medicine, Capital Region Blood Bank, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
Jakob StensballeDepartment of Anesthesiology and Trauma Center, Center for Head and Orthopedics, and Section for Transfusion Medicine, Capital Region Blood Bank, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
Marc MaegeleDepartment for Traumatology and Orthopedic Surgery, Cologne-Merheim Medical Center, University of Witten/Herdecke, Cologne, Germany.
J C GoslingsTrauma Unit, Department of Surgery, Academic Medical Center, Amsterdam, the Netherlands.
Karim BrohiTrauma Sciences, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
TACTIC partners
Academic Medical Center · NLOslo University Hospital · NOAmsterdam University Medical Centers · NLRigshospitalet · DKNHS Blood and Transplant · GBQueen Mary University of London · GBWitten/Herdecke University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Essentials The response of thromboelastometry (ROTEM) parameters to therapy is unknown. We prospectively recruited hemorrhaging trauma patients in six level-1 trauma centres in Europe. Blood products and pro-coagulants prevent further derangement of ROTEM results. ROTEM algorithms can be used to treat and monitor trauma induced coagulopathy. SUMMARY: Background Rotational thromboelastometry (ROTEM) can detect trauma-induced coagulopathy (TIC) and is used in transfusion algorithms. The response of ROTEM to transfusion therapy is unknown. Objectives To determine the response of ROTEM profiles to therapy in bleeding trauma patients. Patients/Methods A prospective multicenter study in bleeding trauma patients (receiving ≥ 4 red blood cell [RBC] units) was performed. Blood was drawn in the emergency department, after administration of 4, 8 and 12 RBC units and 24 h post-injury. The response of ROTEM to plasma, platelets (PLTs), tranexamic acid (TXA) and fibrinogen products was evaluated in the whole cohort as well as in the subgroup of patients with ROTEM values indicative of TIC. Results Three hundred and nine bleeding and shocked patients were included. A mean dose of 3.8 g of fibrinogen increased FIBTEM CA5 by 5.2 mm (IQR: 4.1-6.3 mm). TXA administration decreased lysis by 5.4% (4.3-6.5%). PLT transfusion prevented further derangement of parameters of clot formation. The effect of PLTs on EXTEM ca5 values was more pronounced in patients with a ROTEM value indicative of TIC than in the whole cohort. Plasma transfusion decreased EXTEM clotting time by 3.1 s (- 10 s to 3.9 s) in the whole cohort and by 10.6 s (- 45 s to 24 s) in the subgroup of patients with a ROTEM value indicative of TIC. Conclusion The effects of therapy on ROTEM values were small, but prevented further derangement of test results. In patients with ROTEM values indicative of TIC, the efficacy of PLTs and plasma in correcting deranged ROTEM parameters is possibly more robust.

Indexed as

Decision Support TechniquesHemostasisPatient-Centered CareThrombelastographyAdultAntifibrinolytic AgentsClinical Decision-MakingErythrocyte TransfusionEuropeFemaleFibrinogenHemorrhageHumansMaleMiddle AgedPatient SelectionAntifibrinolytic AgentsFibrinogenTranexamic AcidhemorrhageROTEMtransfusiontraumaviscoelastic hemostatic assay

Identifiers

PMID30609290
PMCPMC6850475
OpenAlexW2907829093

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.